In 1984, with an early vision of the importance of obtaining biological response modifiers for use in clinical medicine to fight aging-related diseases, cancer, and other diseases, Dr. Roman Rodriguez Martin created and founded a new laboratory that he named “Laboratorio de Biomoduladores” (Biomodulators Laboratory). In this laboratory, Dr. Roman Rodriguez Martin discovered and led the development of a thymus factor that has an immunomodulatory effect. He named this thymic factor “Biomodulina T” (BMT) due to its main action as a biomodulator, and the letter T was chosen due to the origin of these factors, namely, the thymus gland, and the fundamental action of these factors in stimulating T lymphocytes.